Citations for
1NXNL1, NXNL2
Thioredoxin rod-derived cone viability factor protects against photooxidative retinal damage.
Elachouri G, Lee-Rivera I, Clérin E, Argentini M, Fridlich R, Blond F, Ferracane V, Yang Y, Raffelsberger W, Wan J, Bennett J, Sahel JA, Zack DJ, Léveillard T.
Free Radic Biol Med 81:22-9. doi: 10.1016/j.freeradbiomed.2015.01.003. Epub 2015 Jan 14. 2015
2NXNL1, NXNL2
Transcriptional regulation of nucleoredoxin-like genes takes place on a daily basis in the retina and pineal gland of rats.
Wolloscheck T, Kunst S, Kelleher DK, Spessert R.
Vis Neurosci 32:E002. doi: 10.1017/S0952523814000352. 2015
3NXNL1, NXNL2
Nxnl2 splicing results in dual functions in neuronal cell survival and maintenance of cell integrity.
Jaillard C, Mouret A, Niepon ML, Clérin E, Yang Y, Lee-Rivera I, Aït-Ali N, Millet-Puel G, Cronin T, Sedmak T, Raffelsberger W, Kinzel B, Trembleau A, Poch O, Bennett J, Wolfrum U, Lledo PM, Sahel JA, Léveillard T.
Hum Mol Genet 21(10):2298-311. doi: 10.1093/hmg/dds050. Epub 2012 Feb 15. 2012
4NXNL1, NXNL2
Expression of rod-derived cone viability factor: dual role of CRX in regulating promoter activity and cell-type specificity.
Lambard S, Reichman S, Berlinicke C, Niepon ML, Goureau O, Sahel JA, Léveillard T, Zack DJ.
PLoS One 5(10):e13075. doi: 10.1371/journal.pone.0013075. 2010
5NXNL2
Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential.
Chalmel F, Léveillard T, Jaillard C, Lardenois A, Berdugo N, Morel E, Koehl P, Lambrou G, Holmgren A, Sahel JA, Poch O.
BMC Mol Biol 8:74. 2007
6NXNL2, ZNF366, ZNF367
Fugu and human sequence comparison identifies novel human genes and conservednon-coding sequences.
Gilligan P, Brenner S, Venkatesh B.
Gene 294(1-2):35. 2002